A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

NCT05293496 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Castration-Resistant Prostatic Cancer
Malignant Melanoma
Pancreatic Ductal Carcinoma
Hepatocellular Cancer
Epithelial Ovarian Cancer
Renal Cell Carcinoma

Interventions

BIOLOGICAL: vobramitamab duocarmazine
BIOLOGICAL: lorigerlimab

Sponsor

MacroGenics